X-Chem

X-Chem

Revolutionizing drug discovery with AI-powered small molecule development using ArtemisAI.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round

N/A

Acquisition
Total Funding000k
More about X-Chem
Made with AI
Edit

X-ChemRx operates in the pharmaceutical and biotechnology sector, specializing in the discovery and development of small molecule drugs. The company leverages its proprietary ArtemisAI platform, which utilizes a suite of machine learning models and extensive DNA-encoded chemical library (DEL) data to accelerate the drug discovery process. X-ChemRx serves pharmaceutical companies, biotech firms, and academic institutions, providing them with advanced tools to identify and develop new drug candidates more efficiently. The business model revolves around offering drug discovery services and licensing its technology to clients, generating revenue through service fees and licensing agreements. By integrating AI and machine learning, X-ChemRx aims to revolutionize the way new medicines are discovered, making the process faster and more effective.

Keywords: AI-powered, drug discovery, small molecules, ArtemisAI, machine learning, DEL data, pharmaceutical, biotechnology, drug development, licensing.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by X-Chem

Edit
GlamorousAI
ACQUISITION by X-Chem Oct 2021
ComInnex
ACQUISITION by X-Chem Oct 2021